-
China encourages production of 34 generic medicines
2019-06-24
Chinese authorities on June 21 released a list of 34 generic medicines, encouraging pharmaceutical firms to develop and produce them.
-
Li Li stresses NMPA's mission of ensuring drug safety and effectiveness
2019-06-24
Li Li, Secretary of the NMPA Leading Party Group, emphasized acting on the people-centered philosophy of development and ensuring drug safety and effectiveness during an inspection in Suzhou, Jiangsu province between June 17 and June 20.
-
India-China Drug Regulation Meeting held in Shanghai
2019-06-24
The India-China Drug Regulation Meeting was held in Shanghai on June 21, a move to promote public health and strengthen exchanges and collaboration between the drug regulatory authorities and the pharmaceutical industries of the two countries.
-
NMPA Commissioner Jiao Hong attends the Global Health Forum of Boao Forum for Asia
2019-06-14
On June 11, 2019, Madame Jiao Hong, Commissioner of the National Medical Products Administration (NMPA), attended the first Global Health Forum of the Boao Forum for Asia held in the city of Qingdao.
